Arthur Fratamico, Chief Business Officer at Vitae Pharmaceuticals, Inc (VTAE), bought 10,000 shares at $7.83 ($78K) on 2015-08-27, disclosed to the SEC on 2015-08-31.
Open-market purchase of $78k VTAE by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.